Searched for
SPECIALTY INGREDIENTS IPO
Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?Sudeep Pharma’s strong stock market debut turned into an early rally, with shares gaining up to 8% after listing at a nearly 24% premium to...- Sudeep Pharma sees healthy GMP: How to check IPO allotment on MUFG Intime India and BSE?Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a ...
- Mukul Agrawal-backed Sudeep Pharma IPO fully booked on Day 1 amid strong GMP buzz; should you apply?Sudeep Pharma IPO: Sudeep Pharma's Rs 895 crore IPO saw full subscription on its opening day, driven by strong retail and NII demand, follo...
- Will Sudeep Pharma’s IPO stand out as a long-term growth opportunity?Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export re...
- Gem Aromatics shares surge another 5% after modest listing on NSE, BSE. What should investors do?Gem Aromatics' shares experienced a surge, reaching a day's high of Rs 349 on the BSE after a debut with a modest premium. The IPO, which w...
- Gem Aromatics IPO subscribed 5.17 times on Day 3; GMP 7%. Should you bid? Check other key detailsGem Aromatics’ IPO is seeing initial traction in the grey market, with shares trading at about a 7% premium over the issue price of ₹325. W...
- Gem Aromatics IPO subscribed 2.9 times on Day 2 so far; GMP 7%. Should you bid?Gem Aromatics IPO: Gem Aromatics, a specialty ingredients company, is eyeing a fundraise of about ₹451 crore at the upper price band. The I...
- Gem Aromatics IPO fully booked on Day 1; GMP 8%. Should you subscribe?The Gem Aromatics IPO opened on August 19 and will close on August 21. The specialty ingredients maker plans to raise about ₹451.3 crore at...
- Gem Aromatics files IPO papers with Sebi to mobilise fundsMumbai-based Gem Aromatics, a manufacturer of specialty ingredients, has filled its draft papers with Sebi to raise funds through an initia...
- After strong IPO response, Sanstar shares to debut tomorrow. Here's what GMP suggestsSanstar's shares debuted on exchanges after a highly subscribed IPO. Expected to list at a 32% premium, the company planned to use the proc...
- After robust subscription, Sanstar IPO share allotment to be finalised today. Check status, GMP and other detailsSanstar IPO receives overwhelming response with subscription nearly 83 times, set to finalize share allotment today. Company's shares tradi...
- Sanstar IPO gains momentum on Day 2. Check subscription, GMP and other detailsThe company has fixed a price band of Rs 90-95 per share, where investors can bid for 150 shares in one lot. About 50% in the IPO is reserv...
- Sanstar's Rs 510 crore-IPO opens for subscription. Should you bid?Sanstar IPO: Sanstar Ltd's Rs 510 crore IPO is now open for subscription, with a price band of Rs 90-95 per share. Analysts suggest conside...
- Sanstar IPO fully subscribed within two hours of bidding process, retail portion booked 2XSanstar Ltd's Rs 510 crore initial public offering (IPO) was oversubscribed within two hours on the first day of bidding, driven by strong ...
- Sanstar IPO to open on Friday; what GMP indicates ahead of subscription?Sanstar is aiming to raise ₹510 crore through its IPO, consisting of a fresh issue of ₹397 crore and an offer for sale of up to 1.19 crore ...
- Plant-based specialty product maker Sanstar gets Sebi nod for an IPOSanstar, specializing in plant-based products, approved for IPO to fund Dhule expansion and debt repayment. Third-largest Maize products ma...
- Plant-based specialty product maker Sanstar files DRHP for IPOThe IPO comprises a fresh issue of up to 4 crore shares and an offer for sale of up to 80 lakh by the selling shareholders. The company, in...
- Anupam Rasayan's Rs 760 crore IPO kicks off: Should you subscribe?At the upper limit of the price band, the scrip is asking a PE of 95.2 times trailing 12-month basis on restated EPS of Rs 5.80.
- ETIG Analysis: Five reasons why the pharma sector has been the biggest beneficiary of the pandemicThe events of the recent months prompted the government to roll out an incentive scheme to promote the local production of key active ingre...
- Galaxy Surfactants files papers for IPOExisting shareholders will sell nearly 63,31,674 shares of the company in the IPO, according to the
Load More
